Termination of Registration of a Class of Security Under Section 12(g) (15-12g)

 

	OMB APPROVAL
	OMB Number:	3235-0167
	Expires:	March 31, 2018
	Estimated average burden hours per response      1.50

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 15

 

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION

12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE

REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

 

Commission File Number: 000-28347

 

OncoVista Innovative Therapies, Inc.

(Exact name of registrant as specified in its charter)

 

14785 Omicron Drive, Suite 104, San Antonio, Texas 78245

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

 

Common stock, $0.001 par value

(Title of each class of securities covered by this Form)

 

 

 

(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

 

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

 

	Rule 12g-4(a)(1)	x
	Rule 12g-4(a)(2)	o
	Rule 12h-3(b)(1)(i)	o
	Rule 12h-3(b)(1)(ii)	o
	Rule 15d-6	o
	Rule 15d-22(b)	o

 

Approximate number of holders of record as of the certification or notice date: 226

 

Pursuant to the requirements of the Securities Exchange Act of 1934 OncoVista Innovative Therapies, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

 

Date: May 4, 2016	OncoVista Innovative Therapies, Inc.
	By:	/s/ Alexander L. Weis
	Name:	Alexander L. Weis
	Title:	Chief Executive Officer

 

Instruction: This form is required by Rules 12g-4, 12h-3 and 15d-6 and 15d-22 of the General Rules and Regulations under the Securities Exchange Act of 1934. The registrant shall file with the Commission three copies of Form 15, one of which shall be manually signed. It may be signed by an officer of the registrant, by counsel or by any other duly authorized person. The name and title of the person signing the form shall be typed or printed under the signature.